首页> 美国卫生研究院文献>The Journal of Automatic Chemistry >Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine Asymmetric Dimethylarginine and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD
【2h】

Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine Asymmetric Dimethylarginine and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD

机译:使用HPLC-FLD定量测定人血浆中L-精氨酸不对称二甲基精氨酸和对称二甲基精氨酸的三种样品制备方法的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Increased asymmetric dimethylarginine (ADMA) in human plasma has been associated with reduced generation of nitric oxide, leading to atherosclerotic diseases. ADMA may therefore be an important biomarker for cardiovascular disease. In the present study, three sample preparation techniques were compared regarding the quantification of L-arginine and ADMA in human plasma: (A) protein precipitation (PP) based on aqueous trichloroacetic acid (TCA), (B) PP using a mixture of ammonia and acetonitrile, and (C) solid-phase extraction (SPE). The samples were analysed by using high-performance liquid chromatography with fluorescence detection (HPLC-FLD). The analytical performance of (A) was comparable with that of (C), demonstrating recoveries of >90%, coefficient of variations (CVs, %) of <8, and a resolution (Rs) between ADMA and symmetric dimethylarginine (SDMA) of 1.2. (B) was disregarded due to recoveries below 75%. (A) was validated with good results regarding linearity (>0.994), precision (<5%), and sensitivity (lower limit of quantification (LLOQ)) of 0.14 µM and 12 nM for L-arginine and ADMA, respectively. Due to the simplicity and speed of procedure (A), this approach may serve as preferred sample preparation of human plasma samples before HPLC-FLD in providing important information regarding elevated ADMA concentrations.
机译:人血浆中不对称二甲基精氨酸(ADMA)的增加与一氧化氮的产生减少有关,从而导致动脉粥样硬化疾病。因此,ADMA可能是心血管疾病的重要生物标志物。在本研究中,比较了三种定量制备人血浆中L-精氨酸和ADMA的样品制备技术:(A)基于三氯乙酸水溶液(TCA)的蛋白质沉淀(PP),(B)使用氨水混合物的PP乙腈,以及(C)固相萃取(SPE)。使用具有荧光检测功能的高效液相色谱(HPLC-FLD)对样品进行分析。 (A)的分析性能与(C)相当,表明回收率> 90%,变异系数(CVs,%)<8,ADMA和对称二甲基精氨酸(SDMA)之间的分辨率(Rs)为1.2。 (B)由于回收率低于75%而被忽略。 (A)在L-精氨酸和ADMA的线性(> 0.994),精密度(<5%)和灵敏度(定量下限(LLOQ))分别为0.14μm和12nnM方面均得到了良好的验证。由于步骤(A)的简便性和速度,该方法可作为HPLC-FLD之前人类血浆样品的优选样品制备方法,以提供有关升高的ADMA浓度的重要信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号